References
- Lachance Y, Luu-The V, Labrie C, et al. Characterization of human 3β-hydroxysteroid dehydrogenase/δ5-δ4-isomerase gene and its expression in mammalian cells. J Biol Chem 1990; 265: 20469–75
- Erickson GF, Yen SSC. The polycystic ovary syndrome. The Ovary, EY Adashi, PCK Leung. Raven Press, New York 1993; 561
- Franks S, White DM. Prevalence of and etiological factors in polycystic ovarian syndrome. Ann NY Acad Sci 1993; 687: 112–14
- Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328–32
- Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996; 81: 302–9
- Doldi N, Bassan M, Bonzi V, Ferrari A. Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol Endocrinol 1996; 10: 101–8
- Volpe A, Artini PG, Barreca A, et al. Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients. Hum Reprod 1992; 7: 1347–52
- Donderwinkel PF, Schoot DC, Pache TD, et al. Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist. Hum Reprod 1993; 8: 2027–32
- Erickson GF, Magoffin DA, Garzo VG, et al. Granulosa cells of polycystic ovaries: are they normal or abnormal?. Hum Reprod 1992; 7: 293–9
- Doldi N, Gessi A, Destefani A, et al. Polycystic ovary syndrome: anomalies in progesterone production. Hum Reprod 1998; 13: 290–3
- Doldi N, Marsiglio E, Destefani A, et al. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in vitro fertilization is associated with higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999; 14: 601–5
- Bain PA, Yoo M, Clarke T, et al. Multiple forms of mouse 3β-hydroxysteroid dehydrogenase/δ5-δ4-isomerase and differential expression in gonads, adrenal glands, liver and kidneys of both sexes. Proc Natl Acad Sci USA 1991; 88: 8870–4
- Shifren JL, Doldi N, Ferrara N, et al. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J Clin Endocrinol Metab 1994; 79: 316–22
- Martel C, Labrie C, Couet J, et al. Effects of human chorionic gonadotropin and prolactin on 3-beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4 isomerase expression and activity in the rat ovary. Mol Cell Endocrinol 1990; 72: R7–13
- Jone BB, Hsueh AJ. Regulation of ovarian 3-beta-hydroxysteroid dehydrogenase activity by gonadotropin-releasing hormone and follicle-stimulating hormone in cultured rat granulosa cells. Endocrinology 1982; 110: 1663–7
- Sasano H, Mori T, Sasano N, et al. Immuno-localization of 3-beta-hydroxysteroid dehydrogenase in human ovary. J Reprod Fertil 1990; 89: 743–51
- Tian XC, Berndtson AK, Fortune JE. Differentiation of bovine preovulatory follicles during the follicular phase is associated with increases in messenger ribonucleic acid for cytochrome P450 side-chain cleavage, 3β-hydroxysteroid dehydrogenase, and P450 17α-hydroxylase, but not P450 aromatase. Endocrinology 1995; 136: 5102–10
- Andreani CL, Pierro E, Lazzarin N, et al. Effect of follicular fluid on granulosa luteal cells from polycystic ovary. Hum Reprod 1996; 11: 2107–13